Le 13 juillet dernier, l'émission "Les Eclaireurs" était consacrée à la génétique et à la médecine préventive avec la participation du Pr Edouard Louis (Ensemble) et du Dr Laurent Servais (Baby Detect).
Among the grants awarded by the FRS-FNRS this year, 107 will finance research carried out by ULiège scientists.
The FNRS has selected the research projects to be funded by Télévie: 14 new research projects, 5 multi-university projects and the renewal of 13 ongoing projects.
Le FNRS a diffusé la liste de ses nouveaux mandats. Félicitations aux 35 chercheurs GIGA qui obtiennent un nouveau mandat, et plus particulièrement à Anneline Pinson et Coraline Radermecker qui obtiennent un mandat de chercheur qualifié.
Pioneering research highlights the importance of combining neuroscience with traditional entrepreneurial studies to gain a comprehensive understanding of what makes successful entrepreneurs distinct at a neurological level.
University of Liège researchers discover a new therapeutic target for the treatment of melanoma resistant to targeted therapies.
As part of the Welbio Investigator Program call for projects, two FARAH projects and two GIGA project were selected for funding at the Université de Liège.
The Cellular and Molecular Immunology Laboratory, under the direction of Fabrice Bureau and Christophe Desmet, provides a better understanding of the origin of eosinophils and eosinophilia, and the effects of treatments targeting them.
Julie Bakker's team has shown that puberty is a crucial phase in brain development and that exposure to stresses during this period could lead to long lasting sexual dysfunction.
Gilles Vandewalle's team provides evidence that higher light levels lead to a change in activity in the hypothalamus, and an improvement in cognitive performance.
A new study at ULiège and a call to established entrepreneurs and young entrepreneurs in student incubators
Prof. David Lyden (Weill Cornell Medical College) inaugurated at ULiège the series of lectures and meetings in Belgium on The pre-metastatic nice concept.
The laboratory of Grégory Ehx and his Canadian colleagues discover that azacitidine, a drug used against leukemia, should be combined with autophagy inhibitors to unleash its full potential.
He receives the award for a research project investigating the molecular mechanisms that shape the genome architecture in Ewing's sarcoma, a pediatric cancer.
3 ULiège research centers with different areas of expertise - GIGA (biology - D. Mottet), CIRM (pharmacy - G. Piel) and CERM (chemistry - A. Debuigne) - have successfully joined forces to carry out this multidisciplinary research project.
